The nurse, identified as RN #127, crushed Potassium Chloride Extended Release and Omeprazole Delayed Release at 8:37 that morning. She added the crushed pills to a medicine cup containing pudding and stirred the mixture before administering it to Resident #32, according to federal inspectors who observed the medication administration.
Both medications appear on the facility's own "Medications Not To Be Crushed" list.
The FDA has issued specific guidance warning against crushing either drug. For Omeprazole Delayed Release, FDA guidance from November 2015 states: "Do not crush, break, or chew the tablet. This decreases how well the medication works in the body." For Potassium Chloride Extended Release, April 2018 FDA guidance instructs to "swallow pills whole without crushing."
When interviewed five minutes later, RN #127 confirmed she had crushed both medications.
Resident #32 was admitted to the facility in November 2023 with chronic diastolic congestive heart failure, type II diabetes, and aphasia following a stroke. The resident had a physician's order dated December 24 allowing staff to crush "allowable medications."
The facility's medication administration policy, last revised in October 2023, requires nurses to "check the Do Not Crush list before crushing medications" and to "direct specific questions to the pharmacist." The policy also instructs staff to "contact the ordering physician for a change to different route of administration when the medication cannot be crushed."
Extended-release and delayed-release formulations are designed to release medication slowly over time. Crushing these pills destroys the special coating or matrix that controls the release, potentially causing the entire dose to be absorbed at once rather than gradually.
For potassium chloride, this could lead to dangerous spikes in blood potassium levels. The medication is used to treat low potassium, a condition that can cause dangerous heart rhythm problems if not properly managed.
Omeprazole treats acid reflux by reducing stomach acid production. The delayed-release coating protects the medication from being destroyed by stomach acid before it can reach the small intestine where it's absorbed.
The inspection was conducted in response to a complaint filed as Complaint Number 2671171. Inspectors reviewed medical records for three residents but found medication administration problems affecting only Resident #32.
The facility has 73 residents.
Federal inspectors classified the violation as causing "minimal harm or potential for actual harm" and affecting "few" residents. However, the incident represents a fundamental breakdown in medication safety protocols that the facility had established to prevent exactly this type of error.
The nurse's actions violated multiple layers of safety checks: FDA guidance, the facility's own do-not-crush list, and the medication administration policy requiring consultation with pharmacists or physicians before altering medications that cannot be crushed.
The inspection report does not indicate whether Resident #32 experienced any immediate adverse effects from receiving the improperly administered medications. The report also does not specify how long this practice may have been occurring or whether other residents received similarly crushed medications.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Laurels of West Carrollton The from 2025-12-30 including all violations, facility responses, and corrective action plans.
Additional Resources
- View all inspection reports for Laurels of West Carrollton The
- Browse all OH nursing home inspections